The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

U.S. drugmakers are charging significantly more for new treatments, particularly those targeting rare diseases, as the median ...

U.S. President Donald Trump's trade negotiators are pushing the EU to make unilateral tariff reductions on U.S. goods, saying ...

Eton Pharmaceuticals is able to buy orphan drugs from large pharma companies, where they are too small to matter. Read why ...

A new Reuters analysis has found that prices of newly launched medications in 2024 have more than doubled in the U.S.

Kuick Research Report Gives Detailed Insight On More Than 1400 FDA Orphan Designated Drugs And Highlights More Than USD 190 ...

The European Commission (EC) has granted orphan drug designation to Biodexa Pharmaceuticals’ oral tablet formulation of ...

EMA grants orphan drug designation to Quoin Pharma’s QRX003 for the treatment of Netherton syndrome: Ashburn, Virginia Thursday, May 22, 2025, 15:00 Hrs [IST] Quoin Pharmaceutic ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, ...